233 related articles for article (PubMed ID: 21607190)
21. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.
Taylor GA; Shalita AR
Am J Clin Dermatol; 2004; 5(4):261-5. PubMed ID: 15301572
[TBL] [Abstract][Full Text] [Related]
22. Benzoyl peroxide and clindamycin topical skin preparation decreases Propionibacterium acnes colonization in shoulder arthroscopy.
Dizay HH; Lau DG; Nottage WM
J Shoulder Elbow Surg; 2017 Jul; 26(7):1190-1195. PubMed ID: 28479255
[TBL] [Abstract][Full Text] [Related]
23. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
25. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
[No Abstract] [Full Text] [Related]
26. Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin.
Del Rosso JQ; Stein Gold L; Johnson SM; Rueda MJ; Baldwin H; Lain EL; Landis M; Rendon M; Tanghetti E; Weiss J
J Drugs Dermatol; 2018 Mar; 17(3):264-273. PubMed ID: 29537444
[TBL] [Abstract][Full Text] [Related]
27. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Warner GT; Plosker GL
Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
[TBL] [Abstract][Full Text] [Related]
28. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
29. Cross-sectional Pilot Study of Antibiotic Resistance in Propionibacterium Acnes Strains in Indian Acne Patients Using 16S-RNA Polymerase Chain Reaction: A Comparison Among Treatment Modalities Including Antibiotics, Benzoyl Peroxide, and Isotretinoin.
Sardana K; Gupta T; Kumar B; Gautam HK; Garg VK
Indian J Dermatol; 2016; 61(1):45-52. PubMed ID: 26955094
[TBL] [Abstract][Full Text] [Related]
30. A multicenter efficacy and tolerability evaluation of benzoyl peroxide in a 10% urea vehicle for the treatment of acne vulgaris.
Gold MH
J Drugs Dermatol; 2006 May; 5(5):442-5. PubMed ID: 16703780
[TBL] [Abstract][Full Text] [Related]
31. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
[TBL] [Abstract][Full Text] [Related]
32. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
[TBL] [Abstract][Full Text] [Related]
33. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
[TBL] [Abstract][Full Text] [Related]
34. Cutibacterium acnes persists despite topical clindamycin and benzoyl peroxide.
Heckmann N; Heidari KS; Jalali O; Weber AE; She R; Omid R; Vangsness CT; Rick Hatch GF
J Shoulder Elbow Surg; 2019 Dec; 28(12):2279-2283. PubMed ID: 31471244
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face.
Gupta AK; Lynde CW; Kunynetz RA; Amin S; Choi K; Goldstein E
J Cutan Med Surg; 2003; 7(1):31-7. PubMed ID: 12362264
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
[TBL] [Abstract][Full Text] [Related]
37. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
38. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
Kircik L
Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
Tan HH; Goh CL; Yeo MG; Tan ML
Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
[TBL] [Abstract][Full Text] [Related]
40. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%.
Thielitz A; Sidou F; Gollnick H
J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):747-53. PubMed ID: 17567301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
